Meiling Chen
Impact in
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacological Effects of Natural Compounds
- Parasitology top 10%
Papers in
- Epidemiology 16
- Liver Disease Diagnosis and Treatment 3
-
- Natural product bioactivities and synthesis 3
- Co-authors
- Win L. Chiou (3 shared papers)Swan N. Thung (3 shared papers)Jianshu Zhang (2 shared papers)Thomayant Prueksaritanont (1 shared paper)Xiaoxiao Wang (1 shared paper)M. A. Gerber (1 shared paper)Fenton Schaffner (1 shared paper)Yih-Shyong Lai (1 shared paper)
- Journals
- Talanta (4 papers)Annals of the New York Academy of Sciences (2 papers)BioMed Research International (2 papers)Renal Failure (2 papers)Evidence-based Complementary and Alternative Medicine (2 papers)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Meiling Chen
64 papers receiving 875 citations
Peers
Comparison fields: 5 of 126
- Pharmacology 61
- Parasitology 37
- Nephrology 38
- Renewable Energy, Sustainability and the Environment 81
- Complementary and alternative medicine 41
Countries citing papers authored by Meiling Chen
This map shows the geographic impact of Meiling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Chen more than expected).
Fields of papers citing papers by Meiling Chen
This network shows the impact of papers produced by Meiling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Chen. The network helps show where Meiling Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Meiling Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 78 | |
| 2 | Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas. | 1989 | 75 |
| 3 | 2021 | 64 | |
| 4 | 1983 | 52 | |
| 5 | 1984 | 51 | |
| 6 | 2019 | 34 | |
| 7 | 2005 | 29 | |
| 8 | 2016 | 25 | |
| 9 | 2014 | 25 | |
| 10 | 1983 | 22 | |
| 11 | 2019 | 21 | |
| 12 | 2014 | 19 | |
| 13 | 2019 | 18 | |
| 14 | 2018 | 18 | |
| 15 | 2015 | 18 | |
| 16 | 2023 | 16 | |
| 17 | 2022 | 16 | |
| 18 | 2021 | 15 | |
| 19 | 2024 | 14 | |
| 20 | 2023 | 13 |
About Meiling Chen
Meiling Chen is a scholar working on Epidemiology, Molecular Biology, Plant Science, Biomedical Engineering and Complementary and alternative medicine, having authored 73 papers that have together received 887 indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (6 papers), Advanced Photocatalysis Techniques (3 papers), Tuberculosis Research and Epidemiology (3 papers), Advanced oxidation water treatment (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Nanoplatforms for cancer theranostics (3 papers), Natural product bioactivities and synthesis (3 papers) and Phytochemistry and Biological Activities (3 papers). The work is most often cited by research in Pharmacology (61 citations), Parasitology (37 citations), Nephrology (38 citations), Renewable Energy, Sustainability and the Environment (81 citations) and Complementary and alternative medicine (41 citations). Meiling Chen has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Win L. Chiou, Swan N. Thung, Jianshu Zhang, Thomayant Prueksaritanont, Xiaoxiao Wang, M. A. Gerber, Fenton Schaffner, Yih-Shyong Lai, Xiaoliang Ren and Yao‐Ko Wen. Their work appears in journals such as Talanta, Annals of the New York Academy of Sciences, BioMed Research International, Renal Failure and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.